News & Analysis as of October 18, 2024

Life Sciences

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

Vital Signs: Digital Health Law Update | Spring 2024

Jones Day on 7/22/2024

Welcome to Vital Signs, a curated compilation of the latest legal and regulatory developments in digital health. Our lead article reports on recent developments in the U.S. Food and Drug Administration's ("FDA") regulatory...more

Court Rules in Favor of Manufacturers in 340B Drug Shipment Case

Manatt, Phelps & Phillips, LLP on 5/30/2024

On May 21, the U.S. Court of Appeals for the District of Columbia Circuit upheld the right of pharmaceutical manufacturers to place at least some restrictions on the shipment of 340B drugs to contract pharmacies of 340B...more

AGG Food & Drug Newsletter - July 2021

Arnall Golden Gregory LLP on 7/26/2021

Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more

2019 Highlights in Canadian Life Sciences IP and Regulatory Law

Smart & Biggar on 1/10/2020

In 2019, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. We review top developments below: 1) PMPRB: Amendments to Regulations will come into force July 1, 2020, court...more

4 Results

View per page

Page: of 1

Today's Popular Updates › Pharmacies › Life Sciences

Vital Signs: Digital Health Law Update | Spring 2024

Court Rules in Favor of Manufacturers in 340B Drug Shipment Case

AGG Food & Drug Newsletter - July 2021

2019 Highlights in Canadian Life Sciences IP and Regulatory Law

"My best business intelligence, in one easy email…"